ACHE and early-onset autosomal dominant Alzheimer disease: From a neurological perspective, inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a relevant target in the management of neurodegenerative conditions such as Alzheimer’s disease.